Understanding a lesser-known staph infection

Understanding a lesser-known staph infection

August 28, 2018
Researchers from different Texas A&M campuses unite to investigate how Staphylococcus pseudintermedius causes infection

Harnessing commercialization

February 5, 2018
Newer, faster paths for biomedical research discoveries to reach patients

A new type of antibiotic: Revisiting antibody therapeutics in treating infections like staph

November 17, 2016
How making tweaks to a previously discarded drug might hold the key to defeating MRSA and other infectious diseases

New drug boosts immune system to protect against world’s deadliest infectious diseases

October 14, 2014

Researchers at the Texas A&M Health Science Center (TAMHSC) and the University of Texas MD Anderson Cancer Center have developed a new therapy to stimulate the body’s natural immune system, thereby providing effective protection against a wide range of life-threatening infectious diseases.